Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
Completed · Not applicable
Conditions studied: Cervical Cancer, Precancerous Condition
In brief
RATIONALE: New diagnostic procedures such as fluorescence and reflectance spectroscopy (shining light on tissue and measuring patterns of light reflected) may improve the ability to noninvasively detect cervical intraepithelial neoplasia and dysplasia. PURPOSE: This diagnostic trial is studying how well fluorescence and reflectance spectroscopy during colposcopy work in detecting cervical intraepithelial neoplasia and dysplasia in healthy participants with a history of normal Pap smears.
Key facts
- Study ID
- NCT00084903
- Run by
- M.D. Anderson Cancer Center
- People needed
- 1070
- Starts
- 1998-04-01
- Expected to finish
- 2009-02-01
- Last updated by the study team
- 2012-08-02
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Subjects will be individuals 18 years of age or older, who have voluntarily responded to advertisement in the form of posted flyers or word of mouth.
- Subjects must sign an informed consent indicating awareness of the investigational nature of this study.
You may not qualify if…
- Pregnant individuals will be ineligible for this study.
Where it is running
- M. D. Anderson Cancer Center at University of Texas — Houston, Texas, United States
- British Columbia Cancer Agency - Vancouver Cancer Centre — Vancouver, British Columbia, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.